#tirzepatide

GLP-1 Drugs and Heart Failure: Benefit Seems to Depend on Obesity

GLP-1 drugs cut cardiovascular death broadly, but heart failure hospitalization benefit appears limited to obese patients. Here's what the evidence shows.